Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor

Overview of attention for article published in Pediatric Pulmonology, April 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 6 X users
reddit: 2 Redditors

video: 1 YouTube creator

Readers on

mendeley: 48 Mendeley

So far, Altmetric has seen 8 X posts from 6 X users, with an upper bound of 14,788 followers.

Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor - Singh - 2019 - Pediatric Pulmonology - Wiley Online Library https://t.co/p72J3up3d0

RT @ContinuumAEP: #PediatricPulmonology Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor h…

#PediatricPulmonology Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor https://t.co/gXRlwmPTFs

RT @tfischer78: Delayed infections by Staph or Pseudomonas in patients prescribed CFTR modulators. New research from @IowaMed @UIchildrens…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.